Ocugen, Inc

OCGNNASDAQ · Biological Products, (No Diagnostic Substances)

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

339.0M

on 2026-06-30, from 257.3M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2024-04-18. Not read yet. S-3 ↗

6 of its filings are not read yet.

Warrants

10.60M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

6.6 quarters

$100.1M on 2026-06-30 ÷ $15.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-01-20	Public offering	15,000,000	$1.50	$22.5M	424B5 ↗
2025-08-08	Registered direct offering	20,000,000	$1.00	$20.0M	424B5 ↗

Also on file: up to $30.0M term loans agreed 2024-11-07 8-K ↗ · $1K convertible notes, 2026-05-07 8-K ↗ · $15.0M convertible notes, 2026-05-14 8-K ↗